BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9418859)

  • 1. Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity.
    Li JM; Shen X; Hu PP; Wang XF
    Mol Cell Biol; 1998 Jan; 18(1):110-21. PubMed ID: 9418859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 LTR activity in human CD40-activated B lymphocytes is dependent on NF-kappaB.
    Lapointe R; Lemieux R; Darveau A
    Biochem Biophys Res Commun; 1996 Dec; 229(3):959-64. PubMed ID: 8955000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
    Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B
    J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
    Mallardo M; Dragonetti E; Baldassarre F; Ambrosino C; Scala G; Quinto I
    J Biol Chem; 1996 Aug; 271(34):20820-7. PubMed ID: 8702837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
    Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M
    J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-κB mediated activation of viral gene expression.
    Chaudhary P; Khan SZ; Rawat P; Augustine T; Raynes DA; Guerriero V; Mitra D
    Nucleic Acids Res; 2016 Feb; 44(4):1613-29. PubMed ID: 26538602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements.
    Desai-Yajnik V; Samuels HH
    Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
    Quivy V; Adam E; Collette Y; Demonte D; Chariot A; Vanhulle C; Berkhout B; Castellano R; de Launoit Y; Burny A; Piette J; Bours V; Van Lint C
    J Virol; 2002 Nov; 76(21):11091-103. PubMed ID: 12368351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer.
    Sgarbanti M; Remoli AL; Marsili G; Ridolfi B; Borsetti A; Perrotti E; Orsatti R; Ilari R; Sernicola L; Stellacci E; Ensoli B; Battistini A
    J Virol; 2008 Apr; 82(7):3632-41. PubMed ID: 18216101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat.
    Sun Q; Matta H; Chaudhary PM
    Retrovirology; 2005 Feb; 2():9. PubMed ID: 15713234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
    Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
    J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
    Kretz-Remy C; Bates EE; Arrigo AP
    J Biol Chem; 1998 Feb; 273(6):3180-91. PubMed ID: 9452429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.
    Wires ES; Alvarez D; Dobrowolski C; Wang Y; Morales M; Karn J; Harvey BK
    J Neurovirol; 2012 Oct; 18(5):400-10. PubMed ID: 22618514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase.
    Flory E; Kunz M; Scheller C; Jassoy C; Stauber R; Rapp UR; Ludwig S
    J Biol Chem; 2000 Mar; 275(12):8307-14. PubMed ID: 10722660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
    Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
    Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.
    Ogawa K; Chen F; Kuang C; Chen Y
    Biochem J; 2004 Jul; 381(Pt 2):413-22. PubMed ID: 15086314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
    Schafer SL; Hiscott J; Pitha PM
    Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.